Heron Therapeutics | Passivo Circulante

Current Liabilities Alterar Data
ALKERMES USD 503.11M 15.92M 2023-09
Alnylam Pharmaceuticals USD 967.79M 18M 2023-12
Amarin USD 266.69M 4.24M 2023-09
ANI Pharmaceuticals USD 145.48M 11.12M 2023-12
Arrowhead Research USD 63.72M 41.73M 2023-12
Eisai JPY 307.31B 11.44B 2023-09
GlaxoSmithKline GBP 22.39B 282M 2023-09
Insmed USD 225.63M 28.9M 2023-12
Ligand Pharmaceuticals USD 16.78M 1.06M 2023-12
Merck USD 23.09B 300M 2023-09
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pacira USD 97.38M 3.72M 2023-12
Regeneron Pharmaceuticals USD 4.4B 805.6M 2023-12
Roche Holding CHF 26.21B 1.03B 2023-06
Ultragenyx Pharmaceutical USD 253.98M 9.6M 2023-09
Veracyte USD 61.24M 3.98M 2023-12
Vertex Pharmaceuticals USD 3.6B 247.3M 2023-09



Heron Therapeutics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2024.